Big Pharma layoff rounds jump 281% in '24
CVS Health launches CostVantage model
Orbis raises $93M to turn popular biologics into pills
Novo asks FDA to restrict Victoza compounding amid GLP-1 outsourcing row
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud *please scroll down for all the latest news*
CVS Health launches CostVantage model
Orbis raises $93M to turn popular biologics into pills
Novo asks FDA to restrict Victoza compounding amid GLP-1 outsourcing row
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud *please scroll down for all the latest news*